These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 17390370)

  • 1. Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery: building chiral technology toolboxes.
    McConnell O; Bach A; Balibar C; Byrne N; Cai Y; Carter G; Chlenov M; Di L; Fan K; Goljer I; He Y; Herold D; Kagan M; Kerns E; Koehn F; Kraml C; Marathias V; Marquez B; McDonald L; Nogle L; Petucci C; Schlingmann G; Tawa G; Tischler M; Williamson RT; Sutherland A; Watts W; Young M; Zhang MY; Zhang Y; Zhou D; Ho D
    Chirality; 2007 Sep; 19(9):658-82. PubMed ID: 17390370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid screening of enzymes for the enzymatic hydrolysis of chiral esters in drug discovery.
    Petucci C; Di L; McConnell O
    Chirality; 2007 Sep; 19(9):701-5. PubMed ID: 17575571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of chiral technology in a pharmaceutical company. Enantiomeric separation and spectroscopic studies of key asymmetric intermediates using a combination of techniques. Phenylglycidols.
    McConnell O; He Y; Nogle L; Sarkahian A
    Chirality; 2007 Sep; 19(9):716-30. PubMed ID: 17323324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
    Piras P; Roussel C
    J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectroscopic methods for determining enantiomeric purity and absolute configuration in chiral pharmaceutical molecules.
    Shah RD; Nafie LA
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):764-75. PubMed ID: 11899617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategic use of preparative chiral chromatography for the synthesis of a preclinical pharmaceutical candidate.
    Leonard WR; Henderson DW; Miller RA; Spencer GA; Sudah OS; Biba M; Welch CJ
    Chirality; 2007 Sep; 19(9):693-700. PubMed ID: 17354260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the absolute configuration of the potent histamine H3 receptor antagonist GT-2331 using vibrational circular dichroism.
    Minick DJ; Copley RC; Szewczyk JR; Rutkowske RD; Miller LA
    Chirality; 2007 Sep; 19(9):731-40. PubMed ID: 17575572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereochemical identification of (R)- and (S)-ibuprofen using residual dipolar couplings, NMR, and modeling.
    Marathias VM; Tawa GJ; Goljer I; Bach AC
    Chirality; 2007 Sep; 19(9):741-50. PubMed ID: 17094072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spiroleptosphol isolated from Leptosphaeria doliolum.
    Hashimoto M; Tsushima T; Murakami T; Nomiya M; Takada N; Tanaka K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4228-31. PubMed ID: 18541425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective chromatography in drug discovery.
    Zhang Y; Wu DR; Wang-Iverson DB; Tymiak AA
    Drug Discov Today; 2005 Apr; 10(8):571-7. PubMed ID: 15837600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetry on large scale: the roadmap to stereoselective processes.
    Federsel HJ
    Nat Rev Drug Discov; 2005 Aug; 4(8):685-97. PubMed ID: 16041317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative 1H NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline, and paroxetine.
    Salsbury JS; Isbester PK
    Magn Reson Chem; 2005 Nov; 43(11):910-7. PubMed ID: 16052604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putting chirality to work: the strategy of chiral switches.
    Agranat I; Caner H; Caldwell J
    Nat Rev Drug Discov; 2002 Oct; 1(10):753-68. PubMed ID: 12360254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of difference circular dichroism (CD) spectroscopy for determination of pharmaceutical compounds. Analysis of stereoisomers by the HPLC-CD/UV method].
    Baloghné SA
    Acta Pharm Hung; 2003; 73(3):185-95. PubMed ID: 15112442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
    Schirlin D; Galvan M; Le Fur G
    Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds.
    Calcaterra A; D'Acquarica I
    J Pharm Biomed Anal; 2018 Jan; 147():323-340. PubMed ID: 28942107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A feasibility study on direct assay of an aqueous formulation by chiral supercritical fluid chromatography (SFC).
    Mukherjee PS; Cook SE
    J Pharm Biomed Anal; 2006 Jun; 41(4):1287-92. PubMed ID: 16682161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prologue: chirality in the pharmaceutical industry.
    Caldwell J; Berova N; McConnell O
    Chirality; 2007 Sep; 19(9):657. PubMed ID: 17657706
    [No Abstract]   [Full Text] [Related]  

  • 19. Computational validation of the importance of absolute stereochemistry in virtual screening.
    Brooks WH; Daniel KG; Sung SS; Guida WC
    J Chem Inf Model; 2008 Mar; 48(3):639-45. PubMed ID: 18266348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hit and Lead identification: efficient practices for drug discovery.
    Goodnow RA; Gillespie P
    Prog Med Chem; 2007; 45():1-61. PubMed ID: 17280901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.